Skip to main content
Equibles

Saturn V Capital Management LP

Position in ANRO — Alto Neuroscience, Inc.

CIK 1964437 AUSTIN, TX
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,824,857
+$2,824,160 QoQ
Shares Held
182,829
+105.4% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#31
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Saturn V Capital Management LP holds $614,415,149 across 22 Biotechnology names. ANRO ranks #20 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALMS
Alumis Inc.
 2,915,443 $82,040,566
2 ABVX
Abivax S.A.
 518,865 $69,143,949
3 PCVX
Vaxcyte, Inc.
 852,914 $49,579,890
4 IMMX
Immix Biopharma, Inc.
 4,658,429 $48,028,402
5 PHVS
Pharvaris N.V.
 1,314,122 $45,442,338
6 JAZZ
Jazz Pharmaceuticals plc
 160,938 $38,781,229
7 CELC
Celcuity Inc.
 370,318 $38,742,669
8 IRON
Disc Medicine, Inc.
 524,730 $38,378,752

All Filings in ANRO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,824,857 182,829
2026-03-31 $2,000,697 88,999